Photo of Lim See Wah, CEO of Hyphens Pharma: Albert Chua/The Edge Singapore

Profits of pharmaceutical distributor Hyphens Pharma looks promising for 1QFY2021 following its highest ever quarterly sales.

This translated to a profit margin of 6.3% which comes amid a recovery in demand for its products in Vietnam, analysts from KGI Securities say in a June 28 note. 

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook